A variational bayes discrete mixture test for rare variant association

Genetic Epidemiology

Volumn 38, Issue 1, 2014, Pages 21-30

  Logsdon, Benjamin A ^a,b   Dai, James Y ^a   Auer, Paul L ^a,o   Johnsen, Jill M ^b,c   Ganesh, Santhi K ^d   Smith, Nicholas L ^b,e,f   Wilson, James G ^g   Tracy, Russell P ^h   Lange, Leslie A ⁱ   Jiao, Shuo ^a   Rich, Stephen S ^j   Lettre, Guillaume ^k   Carlson, Christopher S ^a   Jackson, Rebecca D ^l   O'Donnell, Christopher J ^m   Wurfel, Mark M ^b   Nickerson, Deborah A ^b   Tang, Hua ⁿ   Reiner, Alexander P ^a,b   Kooperberg, Charles ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PUGET SOUND BLOOD CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e CENTER FOR HEALTH STUDIES   (United States)

^f Seattle Epidemiologic Research and Information Center   (United States)

^g UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

ⁱ IL   (United States)

^j UNIVERSITY OF VIRGINIA   (United States)

^k MONTREAL HEART INSTITUTE   (Canada)

^l OHIO STATE UNIVERSITY   (United States)

^m FRAMINGHAM HEART STUDY   (United States)

ⁿ STANFORD UNIVERSITY   (United States)

^o UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

more..

Author keywords

Approximate inference; Exome sequencing study; Von Willebrand Factor genetics

Indexed keywords

VON WILLEBRAND FACTOR;

AFRICAN AMERICAN; ARTICLE; EXOME; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; MISSENSE MUTATION; MORRIS AND ZEGGINI METHOD; QUANTITATIVE TRAIT; SEQUENCE KERNEL ASSOCIATION TEST; SIMULATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; VON WILLEBRAND FACTOR GENE; WEIGHTED SUM STATISTIC;

AFRICAN AMERICANS; ALGORITHMS; BAYES THEOREM; EXOME; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; MALE; MODELS, GENETIC; MUTATION, MISSENSE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PHENOTYPE; RESEARCH DESIGN; SEQUENCE ANALYSIS, DNA; SOFTWARE; UNITED STATES; VON WILLEBRAND FACTOR;

EID: 84890185282     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21772     Document Type: Article

References (50)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248-249.
2. Ahmad F, Jan R, Kannan M, Obser T, Hassan MI, Oyen F, Budde U, Saxena R, Schneppenheim R. 2013. Characterisation of mutations and molecular studies of type 2 von Willebrand disease. Thrombosis Haemostasis 109:39-46.
3. Auer PL, Johnsen JM, Johnson AD, Logsdon BA, Lange LA, Nalls MA, Zhang G, Franceschini N, Fox K, Lange EM and others. 2012. Imputation of exome sequence variants into population-based samples and blood-cell-trait-associated loci in african americans: Nhlbi go exome sequencing project. Am J Hum Genet 91:794-808.
4. Badirou I, Kurdi M, Legendre P, Rayes J, Bryckaert M, Casari C, Lenting PJ, Christophe OD, Denis CV. 2012. In vivo analysis of the role of o-glycosylations of von Willebrand factor. PLoS One 7:e37508.
5. Basu S, Pan W. 2011. Comparison of statistical tests for disease association with rare variants. Genet Epidemiol 35:606-619.
6. Beal M. 2003. Variational algorithms for approximate Bayesian inference. PhD Thesis, Gatsby Computational Neuroscience Unit, University College London.
7. Browning S, Browning B. 2007. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 81:1084-1097.
8. Capanu M, Begg CB. 2011. Hierarchical modeling for estimating relative risks of rare genetic variants: properties of the pseudo-likelihood method. Biometrics 67:371-380.
9. Carbonetto P, Stephens M. 2012. Scalable variational inference for bayesian variable selection in regression, and its accuracy in genetic association studies. Bayesian analysis 7:73-108.
10. Chen H, Chen J, Kalbfleisch J. 2001. A modified likelihood ratio test for homogeneity in finite mixture models. J Roy Stat Soc B Met 63:19-29.
11. Dempster A, Laird N, Rubin D. 1977. Maximum likelihood from incomplete data via the em algorithm. J Roy Stat Soc B Met 1-38.
12. Denis CV, Lenting PJ. 2012. von Willebrand factor: at the crossroads of bleeding and thrombosis. Int J Hematol 95:353-361.
13. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11:446-450.
14. Eikenboom J, Hilbert L, Ribba AS, Hommais A, Habart D, Messenger S, Al-Buhairan A, Guilliatt A, Lester W, Mazurier C and others. 2009. Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the mcmdm-1vwd study. J Thrombosis Haemostasis 7:1304-1312.
15. Emond MJ, Louie T, Emerson J, Zhao W, Mathias RA, Knowles MR, Wright FA, Rieder MJ, Tabor HK, Nickerson DA and others. 2012. Exome sequencing of extreme phenotypes identifies dctn4 as a modifier of chronic pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet 44:887-
16. Giannoulatou E, Yau C, Colella S, Ragoussis J, Holmes C. 2008. Genosnp: a variational bayes within-sample snp genotyping algorithm that does not require a reference population. Bioinformatics 24:2209-2214.
17. Goodeve A, Eikenboom J, Castaman G, Rodeghiero F, Federici AB, Batlle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R and others. 2007. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the european study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (mcmdm-1vwd). Blood 109:112-121.
18. Han F, Pan W. 2010. A data-adaptive sum test for disease association with multiple common or rare variants. Hum Hered 70:42-54.
19. Hoffmann TJ, Marini NJ, Witte JS. 2010. Comprehensive approach to analyzing rare genetic variants. PLoS One 5:e13584.
20. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis G. 2012. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44:955-959.
21. Johnsen J, Ginsburg D. 2010. von Willebrand disease. In: Kaushansky K, Licthman M, Beutler E, Kipps T, Seligsohn U, et al. editors, Williams Hematology, New York: McGraw Hill, Inc. pp. 2069-2087.
22. Johnsen JM, Auer PL, Morrison CA, Jiao S, Wei P, Haessler J, Fox K, McGee SR, Smith JD, Carlson CS and others. 2013. Common and rare VWF coding variants, von Willebrand factor levels, and factor VIII in African americans: the NHLBI exome sequencing project. Blood. 122:590-597.
23. Lee S, Wu M, Lin X. 2012. Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13:762-775.
24. Li B, Leal S. 2008. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83:311-321.
25. Li Z, Sillanpää M. 2012. Estimation of quantitative trait locus effects with epistasis by variational Bayes algorithms. Genetics 190:231-249.
26. Logsdon B, Hoffman G, Mezey J. 2010. A variational bayes algorithm for fast and accurate multiple locus genome-wide association analysis. BMC Bioinformatics 11:58-
27. Madsen B, Browning S. 2009. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 5:e1000384-
28. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A and others. 2009. Finding the missing heritability of complex diseases. Nature 461:747-753.
29. Martinelli I. 2005. von Willebrand factor and factor viii as risk factors for arterial and venous thrombosis. In: Mannucci PM editor, Seminars in Hematology. New York: Elsevier, volume 42, pp. 49-55.
30. McCarthy M, Abecasis G, Cardon L, Goldstein D, Little J, et al. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356-369.
31. McClellan J, King M. 2010. Genetic heterogeneity in human disease. Cell 141:210-217.
32. Morgenthaler S, Thilly W. 2007. A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: A cohort allelic sums test (cast). Mutat Res-Fund Mol M 615:28-56.
33. Morris A, Zeggini E. 2010. An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol 34:188-193.
34. Nelson MR, Wegmann D, Ehm MG, Kessner D, St. Jean P, Verzilli C, Shen J, Tang Z, Bacanu S-A, Fraser D and others. 2012. An abundance of rare functional variants in 202 drug target genes sequenced in 14, 002 people. Science 337:100-104.
35. Ng P, Levy S, Huang J, Stockwell T, Walenz B, et al. 2008. Genetic variation in an individual human exome. PLoS Genet 4:e1000160.
36. Parisi G. 1988. Statistical Field Theory. Reading, MA: Addison-Wesley.
37. Price AL, Kryukov GV, de Bakker PIW, Purcell SM, Staples J, Wi L-J, Sunyaev SR. 2010. Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86:832-838.
38. Pritchard JK, Cox NJ. 2002. The allelic architecture of human disease genes: common disease-common variant or not? Hum Mol Genet 11:2417-2423.
39. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ and others. 2007. Plink: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
40. Quintana MA, Berstein JL, Thomas DC, Conti DV. 2011. Incorporating model uncertainty in detecting rare variants: the Bayesian risk index. Genet Epidemiol 35:638-649.
41. Quintana MA, Schumacher FR, Casey G, Bernstein JL, Li L, Conti DV. 2013. Incorporating prior biologic information for high-dimensional rare variant association studies. Hum Hereditary 74:184-195.
42. Smith A, Roberts G. 1993. Bayesian computation via the gibbs sampler and related markov chain monte carlo methods. J Roy Stat Soc B Met 55:3-23.
43. Sunyaev S, Ramensky V, Koch I, Lathe W, Kondrashov AS, Bork P. 2001. Prediction of deleterious human alleles. Hum Mol Genet 10:591-597.
44. Sun J, Zheng Y, Hsu L. 2013. A unified mixed-effects model for rare-variant association in sequencing studies. Genet Epidemiol 37:334-344.
45. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G and others. 2012. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337:64-69.
46. Teschendorff A, Wang Y, Barbosa-Morais N, Brenton J, Caldas C. 2005. A variational bayesian mixture modelling framework for cluster analysis of gene-expression data. Bioinformatics 21:3025-3033.
47. van Schie M, van Loon J, De Maat M, Leebeek F. 2011. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review. J Thrombosis Haemostasis 9:899-908.
48. Visscher P, Brown M, McCarthy M, Yang J. 2012. Five years of gwas discovery. Am J Hum Genet 90:7-15.
49. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. 2011. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89:82-93.
50. Yi N, Zhi D. 2011. Bayesian analysis of rare variants in genetic association studies. Genet Epidemiol 35:57-69.